Bal Pharma Limited (BALPHARMA) Price & Analysis

Bal Pharma Limited, an Indian pharmaceutical enterprise, specializes in the production and distribution of a wide array of medicinal formulations and Active Pharmaceutical Ingredients (APIs) for both domestic and global markets. Its comprehensive product offerings encompass prescription drugs, generic medications, over-the-counter (OTC) remedies, intravenous solutions, and bulk pharmaceutical substances. The company's extensive portfolio of finished products addresses diverse health conditions. This includes items for infectious diseases, pain relief, respiratory conditions, and women's health, marketed under brands such as Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel. Bal Pharma also provides diabetic care solutions, including the Diabend and Diabend M Group brands. Additionally, it offers herbal and Ayurvedic preparations for conditions like prostate enlargement, kidney stones, male infertility, and women's health, available through brands like Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin. The company further develops and commercializes products for cardiovascular health (such as anti-hypertensive and anti-lipidemic agents, along with cardiac care products under the Secremet and Servace brands), obesity management, and products supporting skin and bone health. In addition to formulations, Bal Pharma supplies APIs for a broad range of therapeutic applications, including anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatments. The company also provides solutions for gastrointestinal disorders, hemorrhoids, fistulas, and constipation. Founded in 1987 and headquartered in Bengaluru, India, Bal Pharma Limited actively exports its pharmaceutical goods to various international regions, including Europe, Latin America, Africa, the Far East, and the Middle East.